CRITICAL APPRAISAL OF NEUROPATHIC PAIN GUIDELINES IN ASIA



Rizaldy Taslim Pinzon(1*), Rosa De Lima Renita Sanyasi(2)

(1) Duta Wacana University School of MediYogyakartacine
(2) Internship Doctor at dr. Efram Harsana Air Force Hospital, Jl. Raya Solo, Maospati, Madiun, Kabupaten Magetan, Jawa Timur, Indonesia
(*) Corresponding Author

Abstract


Introduction: Neuropathic pain is often difficult to treat, because it is resistant to many medications and/or because of the adverse effects associated with effective medications. Clinicians may be guided by a number of published guidelines and algorithms for the management of neuropathic pain. It is important for every clinicians to know the quality of guidelines.

Objective: The aim of this study is to assess the quality of neuropathic pain guidelines in Asia using Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument.

Method: The search were obtained to identify neuropathic pain guidelines in Asia. Each guideline were assessed using AGREE II instrument. There are 23 key items organized within 6 domains and each key items are rated on a 7-point scale. After calculating each domain, the result interpreted as a strongly recommended for use in practice, recommended for use with some modification, and not recommended for use in practice.

Result and Discussion: There are 5 guidelines left: a guideline from Philippines, China, South Korea, Malaysia, and Middle East. There are no guideline scored 50% or more on all six domain, thus conclude that all five guidelines hadn’t achieved a satisfactory result. The highest score was obtained by domain 4 and the lowest score was obtained by domain 5 and domain 6.

Conclusion: There is no neuropathic pain guidelines in Asia fulfill the satisfiying criteria according to AGREE II instrument.


Keywords


neuropathic pain, guidelines, Asia





Article Metrics

Abstract views : 295




Copyright (c) 2019 Journal of the Medical Sciences (Berkala ilmu Kedokteran)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

      

Creative Commons License
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) by  Universitas Gadjah Mada is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Based on a work at http://jurnal.ugm.ac.id/bik/.